NASDAQ:JYNT Joint (JYNT) Stock Price, News & Analysis → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free JYNT Stock Alerts $16.13 +0.34 (+2.15%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$15.94▼$16.3950-Day Range$9.14▼$16.1352-Week Range$7.31▼$16.39Volume64,027 shsAverage Volume89,762 shsMarket Capitalization$240.98 millionP/E RatioN/ADividend YieldN/APrice Target$22.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Joint alerts: Email Address Joint MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside36.4% Upside$22.00 Price TargetShort InterestBearish5.34% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.57Based on 27 Articles This WeekInsider TradingN/AProj. Earnings Growth284.62%From $0.13 to $0.50 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.93 out of 5 starsMedical Sector364th out of 903 stocksPatent Owners & Lessors Industry4th out of 7 stocks 3.3 Analyst's Opinion Consensus RatingJoint has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageJoint has only been the subject of 2 research reports in the past 90 days.Read more about Joint's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.34% of the outstanding shares of Joint have been sold short.Short Interest Ratio / Days to CoverJoint has a short interest ratio ("days to cover") of 8.8.Change versus previous monthShort interest in Joint has recently increased by 2.16%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldJoint does not currently pay a dividend.Dividend GrowthJoint does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for JYNT. Previous Next 2.5 News and Social Media Coverage News SentimentJoint has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 27 news articles for Joint this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for JYNT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Joint insiders have not sold or bought any company stock.Percentage Held by Insiders30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Joint's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Joint are expected to grow by 284.62% in the coming year, from $0.13 to $0.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Joint is -21.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Joint is -21.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioJoint has a P/B Ratio of 9.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Joint's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. About Joint Stock (NASDAQ:JYNT)The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.Read More JYNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JYNT Stock News HeadlinesMay 7, 2024 | globenewswire.comThe Joint Corp. to Participate in Upcoming Investor ConferencesMay 7, 2024 | americanbankingnews.comJoint (NASDAQ:JYNT) Upgraded to Buy at StockNews.comMay 8, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. May 7, 2024 | americanbankingnews.comJoint (NASDAQ:JYNT) Earns Buy Rating from Roth MkmMay 7, 2024 | americanbankingnews.comB. Riley Analysts Lift Earnings Estimates for The Joint Corp. (NASDAQ:JYNT)May 6, 2024 | finance.yahoo.comThe Joint Corp. (NASDAQ:JYNT) Q1 2024 Earnings Call TranscriptMay 6, 2024 | americanbankingnews.comQ3 2024 EPS Estimates for The Joint Corp. Reduced by Analyst (NASDAQ:JYNT)May 4, 2024 | markets.businessinsider.comThe Joint Corp (JYNT): Hold Rating Maintained Amidst Transition and Mixed PerformanceMay 8, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. May 4, 2024 | finance.yahoo.comJoint First Quarter 2024 Earnings: EPS Beats ExpectationsMay 4, 2024 | finance.yahoo.comIs The Joint Corp. (NASDAQ:JYNT) Trading At A 48% Discount?May 4, 2024 | cnet.comBest Banks for Joint Accounts for May 2024May 3, 2024 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Joint (JYNT)May 3, 2024 | finance.yahoo.comThe Joint Corp (JYNT) Q1 2024 Earnings: Revenue Grows, Surpassing Analyst ProjectionsMay 2, 2024 | investorplace.comJYNT Stock Earnings: Joint Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | globenewswire.comThe Joint Corp. Reports First Quarter 2024 Financial ResultsMay 1, 2024 | msn.comJoint Q1 2024 Earnings PreviewMay 1, 2024 | markets.businessinsider.comThe Joint earnings: here's what to expectApril 20, 2024 | seekingalpha.comThe Joint Corp. Switches Its Focus To ProfitabilityApril 18, 2024 | finance.yahoo.comThe Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 ResultsApril 18, 2024 | globenewswire.comThe Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 ResultsApril 17, 2024 | finance.yahoo.comThe Joint Chiropractic Proudly Supports Colorado-Based Rachel's ChallengeApril 17, 2024 | prnewswire.comThe Joint Chiropractic Proudly Supports Colorado-Based Rachel's ChallengeApril 17, 2024 | finance.yahoo.comThe Joint Corp. (JYNT)April 2, 2024 | prnewswire.comLogan University Establishes The Joint Chiropractic Endowed ScholarshipMarch 12, 2024 | markets.businessinsider.comOn Holding Posts Adj. Loss In Q4 - Quick FactsMarch 9, 2024 | finance.yahoo.comEarnings Miss: The Joint Corp. Missed EPS And Analysts Are Revising Their ForecastsSee More Headlines Receive JYNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/07/2024Today5/07/2024Next Earnings (Estimated)9/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Patent owners & lessors Sub-IndustryN/A Current SymbolNASDAQ:JYNT CUSIPN/A CIK1612630 Webwww.thejoint.com Phone(480) 245-5960Fax480-513-7989Employees444Year FoundedN/APrice Target and Rating Average Stock Price Target$22.00 High Stock Price Target$30.00 Low Stock Price Target$16.00 Potential Upside/Downside+36.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.75) Trailing P/E RatioN/A Forward P/E Ratio124.08 P/E GrowthN/ANet Income$-9,750,000.00 Net Margins-9.24% Pretax Margin-0.34% Return on Equity3.94% Return on Assets1.29% Debt Debt-to-Equity RatioN/A Current Ratio1.34 Quick Ratio1.32 Sales & Book Value Annual Sales$117.70 million Price / Sales2.05 Cash Flow$0.73 per share Price / Cash Flow22.21 Book Value$1.68 per share Price / Book9.60Miscellaneous Outstanding Shares14,940,000Free Float10,425,000Market Cap$240.98 million OptionableOptionable Beta1.58 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Peter D. Holt (Age 65)CEO, President & Director Comp: $469.55kJake Singleton (Age 42)Chief Financial Officer Comp: $280.92kMr. Jorge ArmenterosSenior Vice President of OperationsMr. Charles NellesChief Technology OfficerDr. Steven KnaufVice President of Chiropractic & ComplianceMs. Lori I. Abou Habib (Age 44)Chief Marketing Officer Ms. Krischelle TennessenChief Human Resources OfficerMr. Eric SimonSenior VP of Franchise Sales & DevelopmentMr. Craig P. Colmar J.D. (Age 71)Secretary Comp: $37kMore ExecutivesKey Competitors23andMeNASDAQ:MEAVITA MedicalNASDAQ:RCELMetagenomiNASDAQ:MGXFoghorn TherapeuticsNASDAQ:FHTXVeruNASDAQ:VERUView All CompetitorsInsiders & InstitutionsJCP Investment Management LLCBought 15,000 shares on 5/7/2024Ownership: 0.755%Bridge City Capital LLCBought 9,492 shares on 4/12/2024Ownership: 0.150%Avondale Wealth ManagementBought 12,500 shares on 4/2/2024Ownership: 0.129%Sierra Summit Advisors LLCBought 67,857 shares on 2/22/2024Ownership: 0.460%Corsair Capital Management L.P.Bought 25,851 shares on 2/14/2024Ownership: 0.175%View All Insider TransactionsView All Institutional Transactions JYNT Stock Analysis - Frequently Asked Questions Should I buy or sell Joint stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" JYNT shares. View JYNT analyst ratings or view top-rated stocks. What is Joint's stock price target for 2024? 4 brokerages have issued 12-month price objectives for Joint's stock. Their JYNT share price targets range from $16.00 to $30.00. On average, they predict the company's share price to reach $22.00 in the next year. This suggests a possible upside of 36.4% from the stock's current price. View analysts price targets for JYNT or view top-rated stocks among Wall Street analysts. How have JYNT shares performed in 2024? Joint's stock was trading at $9.61 on January 1st, 2024. Since then, JYNT stock has increased by 67.8% and is now trading at $16.13. View the best growth stocks for 2024 here. When is Joint's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 11th 2024. View our JYNT earnings forecast. How were Joint's earnings last quarter? The Joint Corp. (NASDAQ:JYNT) released its earnings results on Thursday, March, 7th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.04. The firm earned $30.61 million during the quarter, compared to analyst estimates of $29.63 million. Joint had a positive trailing twelve-month return on equity of 3.94% and a negative net margin of 9.24%. What is Peter D. Holt's approval rating as Joint's CEO? 87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Joint own? Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE). When did Joint IPO? Joint (JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager. Who are Joint's major shareholders? Joint's stock is owned by a variety of retail and institutional investors. Top institutional investors include JCP Investment Management LLC (0.76%), Bridge City Capital LLC (0.15%) and Avondale Wealth Management (0.13%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella. View institutional ownership trends. How do I buy shares of Joint? Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:JYNT) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorStock-Picking AI Predicts #1 Stock of 2024AltimetryThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
